SVWAG
SRPT icon

Sound View Wealth Advisors Group’s Sarepta Therapeutics SRPT Stock Holding History

Sound View Wealth Advisors Group’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,695
Closed -$245K – 435
2025
Q3 		$245K Buy
12,695
+728
+6% +$13K 0.02% 387
2025
Q2 		$205K Buy
11,967
+7,104
+146% +$303K 0.02% 409
2025
Q1 		$310K Buy
4,863
+771
+19% +$81.2K 0.03% 323
2024
Q4 		$498K Buy
4,092
+498
+14% +$61K 0.04% 261
2024
Q3 		$449K Buy
3,594
+1,715
+91% +$237K 0.04% 269
2024
Q2 		$297K Buy
+1,879
New +$241K 0.03% 303

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Sound View Wealth Advisors Group's SRPT Position: Q4 2025 in Review

Sound View Wealth Advisors Group sold out of Sarepta Therapeutics (SRPT) in Q4 2025, closing a stake of 12,695 shares — an estimated $245K sold.

Sound View Wealth Advisors Group first reported a position in SRPT in Q2 2024 and held it in 6 quarters. The position peaked at $498K in Q4 2024. 347 funds tracked by Wall St. Rank hold SRPT as of Q4 2025.

  • Sound View Wealth Advisors Group reported no remaining Sarepta Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Sound View Wealth Advisors Group sold 12,695 Sarepta Therapeutics shares in Q4 2025, an estimated $245K.
  • Sound View Wealth Advisors Group first reported a position in Sarepta Therapeutics in Q2 2024 and held it in 6 quarters.
  • Sound View Wealth Advisors Group's Sarepta Therapeutics position peaked at $498K in Q4 2024.
  • 347 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2025.

Based on Sound View Wealth Advisors Group's 13F filing for Q4 2025, filed 8 Jan 2026.